tm logo

Monitor this mark

View On USPTO

EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 15 Nov 2011

Last Applicant/ Owned by

Bristol-Myers Squibb Company

345 Park Avenue

New York

NY

10154

Serial Number

78844268 filed on 23rd Mar 2006

Registration Number

N/A

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly

Trademark Department

345 Park Avenue

New York NY 10154

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

EARLY SUPERIOR HBV DNA REDUCTION WITH ENTECAVIR VS. ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBEAG (+) NUCLEIOSIDE NAIVE ADULTS IN A 12-WEEK VIRAL KINETICS STUDY

Medical and scientific research, namely, conducting clinical trials and clinical studies

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Medical and scientific research, namely, conducting clinical trials and clinical studies

First Use Date in General

06th Apr 2006

First Use Date in Commerce

06th Apr 2006

Mark Details

Serial Number

No 78844268

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
15th Nov 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
15th Nov 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
19th Apr 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19th Apr 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18th Apr 2011NON-FINAL ACTION MAILED
15th Apr 2011SU - NON-FINAL ACTION - WRITTEN
22nd Feb 2011STATEMENT OF USE PROCESSING COMPLETE
16th Feb 2011USE AMENDMENT FILED
16th Feb 2011TEAS STATEMENT OF USE RECEIVED
06th Aug 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED